Follow the AILERON THERAPEUTICS INC share price and the full insider trade history of the company, a listed issuer based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). The latest transaction was reported on 6 March 2024 (Levée d'options). Among the most active insiders: WINDSOR JAMES BRIAN. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
AILERON THERAPEUTICS INC is a biopharmaceutical company focused on developing peptide-based therapies for serious diseases. It is listed on NASDAQ under the ticker AILN.